Stay updated on Defactinib and VS-6766 in Uveal Melanoma Clinical Trial
Sign up to get notified when there's something new on the Defactinib and VS-6766 in Uveal Melanoma Clinical Trial page.

Latest updates to the Defactinib and VS-6766 in Uveal Melanoma Clinical Trial page
- Check2 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4, signaling a page version update without changes to the study details.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page's revision tag updated from v3.5.2 to v3.5.3, indicating a minor build update. It does not alter study details or other visible content.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedRevision tag updated to v3.5.2; the previous tag v3.5.0 has been removed.SummaryDifference0.0%

- Check59 days agoChange DetectedRevision: v3.5.0 has been added and Revision: v3.4.3 has been removed.SummaryDifference0.0%

- Check66 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This change does not affect study details or page content.SummaryDifference0.0%

- Check95 days agoChange DetectedThe additions and deletions appear to be administrative, updating the page version to v3.4.2 and removing an outdated funding-status notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Defactinib and VS-6766 in Uveal Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Defactinib and VS-6766 in Uveal Melanoma Clinical Trial page.